跳至主要内容
临床试验/CTRI/2023/11/060355
CTRI/2023/11/060355招募中Phase 3 4

A Comparative Clinical Study to Evaluate the Therapeutic Efficacy of Different Modalities of Ruksha Pinda Sweda in the Management of Amavata W.S.R Rheumatoid Arthritis.

DR PRATHAMESH UMAKANT PANDEY1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年10月12日最近更新:

试验速览

阶段
Phase 3 4
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
VAS scale, 2010 ACR EULAR classification criteria for Rheumatoid Arthritis, ROM by Goniometer

研究概览

简要总结

Amavata, as described in Ayurveda, is a condition resulting from factors like an incompatible diet, weak digestion, and a sedentary lifestyle, exacerbated by indulgence in unctuous foods and exercise. Ama, a product of incomplete metabolism, accumulates in the body and is driven by vitiated Vata to affect various areas, leading to symptoms like body pain, loss of appetite, fatigue, and joint-related issues. Rheumatoid Arthritis (RA) is a systemic autoimmune disease primarily impacting joints, causing symmetrical arthritis, cartilage and bone damage. It affects approximately 1% of the world’s population, with a higher prevalence in women. Management is complex, involving medication, dietary control, and lifestyle changes, but internal medications may not always provide optimal results. In Ayurveda, Amavata is treated with therapeutic techniques like Swedana, Langhana, and herbal preparations like Tikta-Katu Deepana. Swedana, which uses specific heated medicines, enhances metabolic activity, a key aspect of Amavata management. Ruksha Pinda Sweda, involving dry heated boluses, is commonly used, with Valuka Sweda as an ancillary treatment. A comparative study explores alternative therapies like Karisha and Ayas Pinda Sweda’s efficacy for Amavata. Both systems, Ayurveda and modern medicine, address joint-related conditions, offering holistic and integrated approaches to improve the quality of life for those affected.

研究设计

研究类型
Interventional
分配方式
Random Number Table
盲法
Not Applicable

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients fulfilling diagnostic criteria.
  • Participants satisfying 2010 ACR EULAR classification criteria for rheumatoid arthritis.
  • Patients having a clinical presentation of Amavata.

排除标准

  • Patients with major systemic illnesses like cardiac disease, uncontrolled hypertension, kidney disease, and uncontrolled diabetes mellitus.
  • Those who have undergone surgical treatment in affected joints.
  • Patients who report any untoward symptoms during the period of study.

结局指标

主要结局

VAS scale, 2010 ACR EULAR classification criteria for Rheumatoid Arthritis, ROM by Goniometer

时间窗: 1,7 & 14 Day

次要结局

  • Anthropometric measurement of big joints by measuring tape & Jeweler’s ring sizer(measurement for small joints.)

研究者

发起方
DR PRATHAMESH UMAKANT PANDEY
申办方类型
Other [SELF SPONSOR]

研究点 (1)

Loading locations...

相似试验